-
Loading metrics
Open Access
Peer-reviewed
Research Article
A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)
-
Gavin J. Churchyard ,
* E-mail: gchurchyard@auruminstitute.org
Affiliations Aurum Institute for Health Research, Klerksdorp, South Africa, Centre for AIDS Programme of Research in South Africa (CAPRISA), University of Kwa-Zulu Natal, Durban, South Africa
⨯ -
Cecilia Morgan,
Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ -
Elizabeth Adams,
Affiliation Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health (NIH), Bethesda, Maryland, United States of America
⨯ -
John Hural,
Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ -
Barney S. Graham,
Affiliation Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America
⨯ -
Zoe Moodie,
Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ -
Doug Grove,
Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ -
Glenda Gray,
Affiliation Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
⨯ -
Linda-Gail Bekker,
Affiliation Desmond Tutu HIV Foundation, University of Cape Town, Cape Town, South Africa
⨯ -
M. Juliana McElrath,
Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ -
Georgia D. Tomaras,
Affiliation Duke University Medical Center, Durham, North Carolina, United States of America
⨯ -
Paul Goepfert,
Affiliation University of Alabama, Birmingham, Alabama, United States of America
⨯ -
Spyros Kalams,
Affiliation Vanderbilt University, Nashville, Tennessee, United States of America
⨯ -
Lindsey R. Baden,
Affiliation Harvard-Brigham and Women's Hospital, Boston, Massachusetts, United States of America
⨯ -
Michelle Lally,
Affiliation Alpert Medical School of Brown University and Miriam Hospital, Providence, Rhode Island, United States of America
⨯ -
Raphael Dolin,
Affiliation Harvard Medical School- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America
⨯ -
William Blattner,
Affiliation University of Maryland, College Park, Maryland, United States of America
⨯ -
Artur Kalichman,
Affiliation Centro de Referencia e Treinamento em DST/AIDS, Coordenacao dos Institutos de Pesquisa, San Paulo, Brazil
⨯ -
J. Peter Figueroa,
Affiliation Epidemiology Research and Training Unit (ERTU), Kingston, Jamaica
⨯ -
Jean Pape,
Affiliation Cornell-GHESKIO, Institut National de Laboratoire et de Recherches, Port au Prince, Haiti
⨯ -
Mauro Schechter,
Affiliation Projeto Praça Onze, Hospital Escola São Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
⨯ -
Olivier Defawe,
Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ -
Stephen C. De Rosa,
Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ -
David C. Montefiori,
Affiliation Duke Human Vaccine Institute, School of Medicine, Duke University, Durham, North Carolina, United States of America
⨯ -
Gary J. Nabel,
Affiliation Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America
⨯ -
Lawrence Corey,
Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ -
Michael C. Keefer,
Affiliation Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, New York, United States of America
⨯ - [ ... ],
- and the NIAID HIV Vaccine Trials Network
- [ view all ]
- [ view less ]
A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)
- Gavin J. Churchyard,
- Cecilia Morgan,
- Elizabeth Adams,
- John Hural,
- Barney S. Graham,
- Zoe Moodie,
- Doug Grove,
- Glenda Gray,
- Linda-Gail Bekker,
- M. Juliana McElrath
- Published: August 3, 2011
- https://doi.org/10.1371/journal.pone.0021225